IP Library Granted Patent US 11,214,792
Granted Patent B2
US 11,214,792 · App. 16/410,767 · Granted Jan 4, 2022

Continuous directed evolution

Inventors: David R. Liu (Lexington, MA); Kevin Michael Esvelt (Cambridge, MA); Jacob Charles Carlson (Somerville, MA)
Assignee: President and Fellows of Harvard College
C12N15/1058C07K14/005C12N7/00C12N15/70C12N15/85C12N15/86C40B40/08C12N2795/14121C12N2795/14152C40B50/06C40B60/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,214,792
App. No.
16/410,767
Filed
May 13, 2019
Granted
Jan 4, 2022
Kind
B2
Art Unit
1639
USPC
506/17
Abstract

The invention provides systems, methods, reagents, apparatuses, vectors, and host cells for the continuous evolution of nucleic acids. For example, a lagoon is provided in which a population of viral vectors comprising a gene of interest replicates in a stream of host cells, wherein the viral vectors lack a gene encoding a protein required for the generation of infectious viral particles, and wherein that gene is expressed in the host cells under the control of a conditional promoter, the activity of which depends on a function of the gene of interest to be evolved. Some aspects of this invention provide evolved products obtained from continuous evolution procedures described herein. Kits containing materials for continuous evolution are also provided.

Claims (25)

1. A vector system for phage-based continuous directed evolution comprising:

(a) a population of M13 phages comprising:

(i) a gene of interest to be evolved: and

(ii) all phage genes required to generate infectious phage particles, except a functional pIII gene;

wherein the M13 phages lack a functional pIII gene required for the generation of infectious phage, wherein the M13 phages allow for expression of the gene of interest in host cells, and wherein the host cells are suitable host cells for M13 phage infection, replication, and packaging; and

(b) an expression construct comprising a functional pIII gene required to generate infectious phage particles under the control of a conditional promoter, wherein the conditional promoter is activated by a function of a gene product encoded by the gene of interest, wherein the expression construct further encodes a pIII-neg protein under the control of a different promoter than the promoter controlling the functional pIII gene.

2. The vector system of claim 1 , wherein the M13 phage genome comprises a pI, pII, pIV, pV, pVI, pVII, pVIII, pIX, and a pX gene, but not a functional pIII gene.

3. The vector system of claim 1 , wherein the M13 phage genome comprises an F1 origin of replication.

4. The vector system of claim 1 , wherein the M13 phage genome comprises a 3′-fragment of a pIII gene.

5. The vector system of claim 1 , wherein the M13 phage genome comprises a multiple cloning site operably linked to a promoter.

6. The vector system of claim 1 further comprising a helper phage, and together the helper phage and the expression construct comprise all genes required for the generation of an infectious phage.

7. The vector system of claim 1 , wherein the conditional promoter comprises a cI binding site.

8. The vector system of claim 1 , wherein the promoter controlling expression of the pIII-neg protein comprises a cI binding site.

9. The vector system of claim 1 , wherein the vector system further comprises a mutagenesis plasmid comprising a gene expression cassette encoding a mutagenesis-promoting gene product.

10. The vector system of claim 9 , wherein the expression cassette comprises a nucleic acid encoding a gene involved in the SOS response.

11. The vector system of claim 10 , wherein the gene involved in the SOS response is UmuC, UmuD′, and/or RecA.

12. The vector system of claim 9 , wherein the expression cassette encoding a mutagenesis-promoting gene product comprises a conditional promoter, the activity of which depends on the presence of an inducer.

13. The vector system of claim 1 further comprising a population of the host cells, wherein the host cells are E. coli cells.

14. The vector system of claim 10 , wherein the expression cassette comprises UmuC.

15. The vector system of claim 10 , wherein the expression cassette comprises UmuD′.

16. The vector system of claim 10 , wherein the expression cassette comprises UmuC and UmuD′.

17. The vector system of claim 16 , wherein the expression cassette further comprises dnaQ926.

18. The vector system of claim 17 , wherein the expression cassette further comprises recA730.

19. The vector system of claim 12 , wherein the inducer is arabinose.

20. The vector system of claim 12 , wherein the conditional promoter is a pBAD promoter.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2019
From: LIU, DAVID R.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 050440/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2019
From: CARLSON, JACOB; ESVELT, KEVIN M.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 050440/0403 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 20, 2019
From: HOWARD HUGHES MEDICAL INSTITUTE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 050453/0022 →
Continuity (4)
Division 15188627 · Jun 21, 2016
Continuation 13996208
Provisional Application 61426139 · Dec 22, 2010
Related Publication 20190276816A1 · Sep 12, 2019
Cited By (4)
US 12,366,009 US 12,378,539 US 12,398,390 US 12,655,182